Musings from The Power List: Gerrit Renner - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Musings from The Power List: Gerrit Renner

  • October 27, 2026

  • 5 min

Share

Clinical Scorecard: Musings from The Power List: Gerrit Renner

At a Glance

CategoryDetail
ConditionAnalytical data science and trustworthy analytical measurements
Key MechanismsData-processing and chemometric approaches that retain uncertainty, quality, and provenance across analytical workflows.
Target PopulationResearchers and practitioners in analytical science, including those working with complex mass-spectrometric data.
Care SettingAnalytical research workflows, from signal recording through processing and scientific interpretation.

Key Highlights

  • Data processing is described as an integral part of analytical measurement, not a separate post-measurement step.
  • Processing steps such as centroiding, feature detection, integration, and modeling introduce assumptions and uncertainty.
  • The research aims to make processing transparent and quantitative, including propagation of uncertainty and quality measures.
  • Machine-actionable analytical data should carry metadata, provenance, uncertainty, and semantic meaning.
  • FAIR data practices are advocated throughout the analytical workflow, beginning at acquisition.

Guideline-Based Recommendations

Diagnosis

    Management

    • Renner describes developing approaches that make processing steps transparent and quantitative, including uncertainty estimates and quality measures that can be propagated through analytical workflows.
    • Renner argues that analytical workflows should preserve FAIR, machine-actionable data and its context from acquisition onward.

    Monitoring & Follow-up

    • Record processing decisions and uncertainty across transformations from detector signal to final result, as advocated by Renner.
    • Retain metadata and provenance to support interpretation and reconstruction of analytical results.

    Risks

    • Renner notes that preprocessing, peak detection, integration, and filtering decisions can substantially affect outcomes.
    • Renner warns that context, provenance, and processing information may be lost when FAIR practices are applied only after data generation and processing.
    • The source says context may be hidden in proprietary formats, software settings, or scientists’ notebooks, and processing decisions can be difficult to reconstruct.

    Patient & Prescribing Data

    Not applicable; the article concerns analytical science and data workflows, not patient care.

    No treatments or prescribing information are discussed.

    Clinical Best Practices

    • Renner describes data structures, algorithms, statistics, and scientific interpretation as parts of the same measurement chain.
    • Renner argues that FAIR and machine-actionable data should be maintained throughout the workflow, beginning at acquisition.
    • Preserve information about how analytical values were produced and their uncertainty and quality, consistent with Renner’s stated research focus.

    Related Resources & Content

      Original Source(s)

      Related Content